Berggren KN, Schulenberg B, Lopez MF, Steinberg TH, Bogdanova A,
Smejkal G, Wang A, Patton WF. 2002. An improved formulation
SYPRO ruby protein gel stain: comparison with the original formulation and with a ruthenium II Tris (bathophenanthroline disulfonate)
formulation. Proteomics 2:486–498.
Bifulco M, Laezza C, Stingo S, Wolff J. 2002. 2′, 3′-Cyclic nucleotide
3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci U S A 99:
1807–1812.
Braun BE, Sandillon F, Edwards A, Matthieu JM, Privat A. 1988. Immunocytochemical localization by electron microscopy of 2′, 3′-cyclic nu- cleotide 3′-phosphodiesterase in developing oligodendrocytes of normal
and mutant brain. J Neurosci 8:3057–3066.
Butt AM, Ibrahim M, Ruge FM, Berry M. 1995. Biochemical subtypes
of oligodendrocyte in the anterior medullary velum of the rat as
revealed by the monoclonal antibody Rip. Glia 14:185–197.
De Angelis DA, Braun PE. 1994. Isoprenylation of brain 2′, 3′-cyclic nucleotide 3′-phosphodiesterase modulates cell morphology. J Neursci Res 39:
386–397.
De Angelis DA, Braun PE. 1996. Binding of 2′, 3′-cyclic nucleotide 3′- phosphodiesterase to myelin: an in vitro study. J Neurochem 66:2523–
2531.
Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG. 1989.
In situ demonstration of mature oligodendrocytes and their processes:
an immunocytochemical study with a new monoclonal antibody, Rip.
Glia 2:380–390.
)
Itoh K. 2002. Culture of oligodendrocytes precursor cells (NG2 /O1 )
)
and oligodendrocytes (NG2 /O1 ) from embryonic rat cerebrum.
Brain Res Brain Res Protoc 10:23–30.
Itoh K, Sakurai Y, Asou H, Umeda M. 2000. Differential expression of
alternatively spliced neural cell adhesion molecule L1 isoforms during
oligodendrocytes maturation. J Neurosci Res 60:579–586.
Jhaveri S, Erzurumlu RS, Friedman B, Schneider GE. 1992. Oligodendrocytes and myelin formation along the optic tract of the developing
